Plummer, R., Vidal, L., Griffin, M., Lesley, M., de Bono, J., Coulthard, S., . . . Boddy, A. V. (2009). Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors. Clinical cancer research, 15(9), 3177. https://doi.org/10.1158/1078-0432.CCR-08-2859
Chicago-Zitierstil (17. Ausg.)Plummer, Ruth, et al. "Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-day Infusion in Patients with Advanced Solid Tumors." Clinical Cancer Research 15, no. 9 (2009): 3177. https://doi.org/10.1158/1078-0432.CCR-08-2859.
MLA-Zitierstil (9. Ausg.)Plummer, Ruth, et al. "Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-day Infusion in Patients with Advanced Solid Tumors." Clinical Cancer Research, vol. 15, no. 9, 2009, p. 3177, https://doi.org/10.1158/1078-0432.CCR-08-2859.